Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 148 articles: HTML format Text format

Single Articles

March 2010
1. SAITO RA , Micke P, Paulsson J, Augsten M, et al
   Forkhead Box F1 Regulates Tumor-Promoting Properties of Cancer-Associated Fibroblasts in Lung Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. NIKOLINAKOS PG , Altorki N, Yankelevitz D, Tran HT, et al
   Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated with Tumor Shrinkage in Early-Stage Non-Small Cell Lung Cancer Patients Treated with Pazopanib.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. AMOS CI , Pinney SM, Li Y, Kupert E, et al
   A Susceptibility Locus on Chromosome 6q Greatly Increases Lung Cancer Risk among Light and Never Smokers.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. MCDERMOTT U , Pusapati RV, Christensen JG, Gray NS, et al
   Acquired Resistance of Non-Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LEE YJ , Koch M, Karl D, Torres-Collado AX, et al
   Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.
   Cancer Res. 2010;70:948-56.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. GRUM-SCHWENSEN B , Klingelhofer J, Grigorian M, Almholt K, et al
   Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.
   Cancer Res. 2010;70:936-47.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. NAGAHAMA Y , Ueno M, Miyamoto S, Morii E, et al
   PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties.
   Cancer Res. 2010;70:1215-24.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. SOS ML , Rode HB, Heynck S, Peifer M, et al
   Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.
   Cancer Res. 2010;70:868-74.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
9. LIN L , Mernaugh R, Yi F, Blum D, et al
   Targeting Specific Regions of the Notch3 Ligand-Binding Domain Induces Apoptosis and Inhibits Tumor Growth in Lung Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. TSENG RC , Lee SH, Hsu HS, Chen BH, et al
    SLIT2 Attenuation during Lung Cancer Progression Deregulates {beta}-Catenin and E-Cadherin and Associates with Poor Prognosis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SEITZER N , Mayr T, Streit S, Ullrich A, et al
    A Single Nucleotide Change in the Mouse Genome Accelerates Breast Cancer Progression.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
12. LEVINA V , Marrangoni A, Wang T, Parikh S, et al
    Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. PATNAIK SK , Kannisto E, Knudsen S, Yendamuri S, et al
    Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer after Surgical Resection.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. SHOWE MK , Vachani A, Kossenkov AV, Yousef M, et al
    Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non-Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
15. LOEBINGER MR , Kyrtatos PG, Turmaine M, Price AN, et al
    Magnetic Resonance Imaging of Mesenchymal Stem Cells Homing to Pulmonary Metastases Using Biocompatible Magnetic Nanoparticles.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. PARDO OE , Latigo J, Jeffery RE, Nye E, et al
    The Fibroblast Growth Factor Receptor Inhibitor PD173074 Blocks Small Cell Lung Cancer Growth In vitro and In vivo.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. BLOMQUIST T , Crawford EL, Mullins D, Yoon Y, et al
    Pattern of Antioxidant and DNA Repair Gene Expression in Normal Airway Epithelium Associated with Lung Cancer Diagnosis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
18. KONSTANTINIDOU G , Bey EA, Rabellino A, Schuster K, et al
    Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.
    Cancer Res. 2009;69:7644-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LIU Y , Liu P, Wen W, James MA, et al
    Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1.
    Cancer Res. 2009;69:7844-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
20. SHI J , Wang DM, Wang CM, Hu Y, et al
    Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition.
    Cancer Res. 2009;69:7180-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. CADIEUX C , Kedinger V, Yao L, Vadnais C, et al
    Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cancer Res. 2009;69:7188-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. MATSUMOTO K , Arao T, Tanaka K, Kaneda H, et al
    mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.
    Cancer Res. 2009;69:7160-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. FLEMING NI , Trivett MK, George J, Slavin JL, et al
    Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
    Cancer Res. 2009;69:7473-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. QU P , Du H, Wang X, Yan C, et al
    Matrix metalloproteinase 12 overexpression in lung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinoma transition.
    Cancer Res. 2009;69:7252-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KIM WY , Jin Q, Oh SH, Kim ES, et al
    Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. CULHANE AC , Quackenbush J
    Confounding Effects in "A Six-Gene Signature Predicting Breast Cancer Lung Metastasis"
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
27. LEI Z , Liu RY, Zhao J, Liu Z, et al
    TGFBR1 Haplotypes and Risk of Non-Small-Cell Lung Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. TAKANO A , Ishikawa N, Nishino R, Masuda K, et al
    Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.
    Cancer Res. 2009;69:6694-703.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. WANG Z , Zheng M, Li Z, Li R, et al
    Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition.
    Cancer Res. 2009;69:6556-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. BRODERICK P , Wang Y, Vijayakrishnan J, Matakidou A, et al
    Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. SUN X , Ritzenthaler JD, Zhong X, Zheng Y, et al
    Nicotine Stimulates PPAR{beta}/{delta} Expression in Human Lung Carcinoma Cells through Activation of PI3K/mTOR and Suppression of AP-2{alpha}
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. FRANCISZKIEWICZ K , Le Floc'h A, Jalil A, Vigant F, et al
    Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
    Cancer Res. 2009;69:6249-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. CHRISTENSEN BC , Marsit CJ, Houseman EA, Godleski JJ, et al
    Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.
    Cancer Res. 2009;69:6315-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LIU PY , Vikis H, James M, Lu Y, et al
    Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus.
    Cancer Res. 2009;69:6290-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. BOUSQUET E , Mazieres J, Privat M, Rizzati V, et al
    Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.
    Cancer Res. 2009;69:6092-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. SONG N , Huang Y, Shi H, Yuan S, et al
    Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
    Cancer Res. 2009;69:6057-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
37. TAKEZAWA K , Okamoto I, Yonesaka K, Hatashita E, et al
    Sorafenib Inhibits Non-Small Cell Lung Cancer Cell Growth by Targeting B-RAF in KRAS Wild-Type Cells and C-RAF in KRAS Mutant Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. YANG E , Boire A, Agarwal A, Nguyen N, et al
    Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SATOMAA T , Heiskanen A, Leonardsson I, Angstrom J, et al
    Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
    Cancer Res. 2009;69:5811-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ZHANG Y , Byun Y, Ren YR, Liu JO, et al
    Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
    Cancer Res. 2009;69:5867-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. YUE W , Sun Q, Landreneau R, Wu C, et al
    Fibulin-5 Suppresses Lung Cancer Invasion by Inhibiting Matrix Metalloproteinase-7 Expression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. RAPONI M , Dossey L, Jatkoe T, Wu X, et al
    MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. VERBISCK NV , Costa ET, Costa FF, Cavalher FP, et al
    ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis.
    Cancer Res. 2009;69:5546-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. RACANELLI AC , Rothbart SB, Heyer CL, Moran RG, et al
    Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
    Cancer Res. 2009;69:5467-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
45. OLKHANUD PB , Baatar D, Bodogai M, Hakim F, et al
    Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. BANDI N , Zbinden S, Gugger M, Arnold M, et al
    miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. DIMEO TA , Anderson K, Phadke P, Feng C, et al
    A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. ICHIHARA E , Ohashi K, Takigawa N, Osawa M, et al
    Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo.
    Cancer Res. 2009;69:5091-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. WU C , Hu Z, Yu D, Huang L, et al
    Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HOLOPAINEN T , Huang H, Chen C, Kim KE, et al
    Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
    Cancer Res. 2009;69:4656-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. PAJER P , Karafiat V, Pecenka V, Prukova D, et al
    Industasis, a promotion of tumor formation by nontumorigenic stray cells.
    Cancer Res. 2009;69:4605-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
52. JAGER M , Schoberth A, Ruf P, Hess J, et al
    The trifunctional antibody ertumaxomab destroys tumor cells that express low levels of human epidermal growth factor receptor 2.
    Cancer Res. 2009;69:4270-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. SHARMA RK , Elpek KG, Yolcu ES, Schabowsky RH, et al
    Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors.
    Cancer Res. 2009;69:4319-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. SENNINO B , Kuhnert F, Tabruyn SP, Mancuso MR, et al
    Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors.
    Cancer Res. 2009;69:4527-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. EBI H , Tomida S, Takeuchi T, Arima C, et al
    Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.
    Cancer Res. 2009;69:4027-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. BARBERO S , Mielgo A, Torres V, Teitz T, et al
    Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis.
    Cancer Res. 2009;69:3755-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
57. DIAZ L , Ceja-Ochoa I, Restrepo-Angulo I, Larrea F, et al
    Estrogens and human papilloma virus oncogenes regulate human ether-a-go-go-1 potassium channel expression.
    Cancer Res. 2009;69:3300-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. MCDERMOTT U , Ames RY, Iafrate AJ, Maheswaran S, et al
    Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-{alpha} Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. HUSSAIN M , Rao M, Humphries AE, Hong JA, et al
    Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. SAVIOZZI S , Ceppi P, Novello S, Ghio P, et al
    Non-Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. SOS ML , Koker M, Weir BA, Heynck S, et al
    PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. DANIEL VC , Marchionni L, Hierman JS, Rhodes JT, et al
    A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. DU G , Jin L, Han X, Song Z, et al
    Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis.
    Cancer Res. 2009;69:3205-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SAITO RA , Watabe T, Horiguchi K, Kohyama T, et al
    Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Cancer Res. 2009;69:2783-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. MOISSOGLU K , McRoberts KS, Meier JA, Theodorescu D, et al
    Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
    Cancer Res. 2009;69:2838-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
66. YUAN JM , Koh WP, Murphy SE, Fan Y, et al
    Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. KHODAREV NN , Pitroda SP, Beckett MA, Macdermed DM, et al
    MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. ROBEY IF , Baggett BK, Kirkpatrick ND, Roe DJ, et al
    Bicarbonate increases tumor pH and inhibits spontaneous metastases.
    Cancer Res. 2009;69:2260-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. MURALIDHARAN-CHARI V , Hoover H, Clancy J, Schweitzer J, et al
    ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.
    Cancer Res. 2009;69:2201-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. SONG SJ , Song MS, Kim SJ, Kim SY, et al
    Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity.
    Cancer Res. 2009;69:2314-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. ALDRICH MC , Selvin S, Hansen HM, Barcellos LF, et al
    CYP1A1/2 Haplotypes and Lung Cancer and Assessment of Confounding by Population Stratification.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. NIKOLOVA DA , Asangani IA, Nelson LD, Hughes DP, et al
    Cetuximab Attenuates Metastasis and u-PAR Expression in Non-Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. SINGER S , Malz M, Herpel E, Warth A, et al
    Coordinated Expression of Stathmin Family Members by Far Upstream Sequence Element-Binding Protein-1 Increases Motility in Non-Small Cell Lung Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. LEWIS VO , Ozawa MG, Deavers MT, Wang G, et al
    The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.
    Cancer Res. 2009;69:1995-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SINGH SV , Warin R, Xiao D, Powolny AA, et al
    Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
    Cancer Res. 2009;69:2117-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
76. JAMES MA , Lu Y, Liu Y, Vikis HG, et al
    RGS17, an Overexpressed Gene in Human Lung and Prostate Cancer, Induces Tumor Cell Proliferation Through the Cyclic AMP-PKA-CREB Pathway.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. EUBANK TD , Roberts RD, Khan M, Curry JM, et al
    Granulocyte Macrophage Colony-Stimulating Factor Inhibits Breast Cancer Growth and Metastasis by Invoking an Anti-Angiogenic Program in Tumor-Educated Macrophages.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. NASARRE P , Thomas M, Kruse K, Helfrich I, et al
    Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.
    Cancer Res. 2009;69:1324-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. RICONO JM , Huang M, Barnes LA, Lau SK, et al
    Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis.
    Cancer Res. 2009;69:1383-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. ZHANG Z , Zeng B, Zhang Z, Jiao G, et al
    Suppressor of cytokine signaling 3 promotes bone marrow cells to differentiate into CD8+ T lymphocytes in lung tissue via up-regulating Notch1 expression.
    Cancer Res. 2009;69:1578-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. KHAWAM K , Giron-Michel J, Gu Y, Perier A, et al
    Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
    Cancer Res. 2009;69:1561-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. NAKANISHI H , Matsumoto S, Iwakawa R, Kohno T, et al
    Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas.
    Cancer Res. 2009;69:1615-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. KHEMTONG C , Kessinger CW, Ren J, Bey EA, et al
    In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles.
    Cancer Res. 2009;69:1651-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. WEISER-EVANS MC , Wang XQ, Amin J, Van Putten V, et al
    Depletion of Cytosolic Phospholipase A2 in Bone Marrow-Derived Macrophages Protects against Lung Cancer Progression and Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. STOLZENBERG-SOLOMON RZ , Hayes RB, Horst RL, Anderson KE, et al
    Serum Vitamin D and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Screening Trial.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. HURST DR , Edmonds MD, Scott GK, Benz CC, et al
    Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. BROET P , Camilleri-Broet S, Zhang S, Alifano M, et al
    Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
    Cancer Res. 2009;69:1055-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. LIU J , Meisner D, Kwong E, Wu XY, et al
    Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
    Cancer Res. 2009;69:1174-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. ZHENG Y , Ritzenthaler JD, Sun X, Roman J, et al
    Prostaglandin E2 Stimulates Human Lung Carcinoma Cell Growth through Induction of Integrin-Linked Kinase: The Involvement of EP4 and Sp1.
    Cancer Res. 2009;69:896-904.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. JIANG T , Collins BJ, Jin N, Watkins DN, et al
    Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
    Cancer Res. 2009;69:845-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. MEMON AA , Jakobsen S, Dagnaes-Hansen F, Sorensen BS, et al
    Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.
    Cancer Res. 2009;69:873-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
92. KIM WY , Oh SH, Woo JK, Hong WK, et al
    Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1{alpha}
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. LI HJ , Everts M, Yamamoto M, Curiel DT, et al
    Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
    Cancer Res. 2009;69:554-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. SINGH S , Varney M, Singh RK
    Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.
    Cancer Res. 2009;69:411-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. LAM TK , Cross AJ, Consonni D, Randi G, et al
    Intakes of Red Meat, Processed Meat, and Meat Mutagens Increase Lung Cancer Risk.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. VAISSIERE T , Hung RJ, Zaridze D, Moukeria A, et al
    Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors.
    Cancer Res. 2009;69:243-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MCCABE MT , Lee EK, Vertino PM
    A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
    Cancer Res. 2009;69:282-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
98. TSUJI T , Ibaragi S, Shima K, Hu MG, et al
    Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.
    Cancer Res. 2008;68:10377-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. KIM S , Buchlis G, Fridlender ZG, Sun J, et al
    Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
    Cancer Res. 2008;68:10247-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. SALA G , Dituri F, Raimondi C, Previdi S, et al
     Phospholipase Cgamma1 is required for metastasis development and progression.
     Cancer Res. 2008;68:10187-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. JEON HS , Dracheva T, Yang SH, Meerzaman D, et al
     SMAD6 Contributes to Patient Survival in Non-Small Cell Lung Cancer and Its Knockdown Reestablishes TGF-{beta} Homeostasis in Lung Cancer Cells.
     Cancer Res. 2008;68:9686-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. SAENGER YM , Li Y, Chiou KC, Chan B, et al
     Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
     Cancer Res. 2008;68:9884-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. BARRET JM , Kruczynski A, Vispe S, Annereau JP, et al
     F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
     Cancer Res. 2008;68:9845-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. GAN PP , Kavallaris M
     Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
     Cancer Res. 2008;68:9817-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. SAWICKI JA
     Fetal microchimerism and cancer.
     Cancer Res. 2008;68:9567-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
106. CHEUNG AF , Dupage MJ, Dong HK, Chen J, et al
     Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer.
     Cancer Res. 2008;68:9459-68.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. PRATILAS CA , Hanrahan AJ, Halilovic E, Persaud Y, et al
     Genetic predictors of MEK dependence in non-small cell lung cancer.
     Cancer Res. 2008;68:9375-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LE MARCHAND L , Derby KS, Murphy SE, Hecht SS, et al
     Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.
     Cancer Res. 2008;68:9137-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. SINGH SV , Powolny AA, Stan SD, Xiao D, et al
     Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice.
     Cancer Res. 2008;68:9503-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. YANO S , Wang W, Li Q, Matsumoto K, et al
     Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.
     Cancer Res. 2008;68:9479-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
111. MIGITA T , Narita T, Nomura K, Miyagi E, et al
     ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer.
     Cancer Res. 2008;68:8547-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. CHIN LJ , Ratner E, Leng S, Zhai R, et al
     A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
     Cancer Res. 2008;68:8535-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. TARANOVA AG , Maldonado D 3rd, Vachon CM, Jacobsen EA, et al
     Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung.
     Cancer Res. 2008;68:8582-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. GUO J , Ibaragi S, Zhu T, Luo LY, et al
     Nicotine promotes mammary tumor migration via a signaling cascade involving protein kinase C and CDC42.
     Cancer Res. 2008;68:8473-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. DAVIS VL , Jayo MJ, Ho A, Kotlarczyk MP, et al
     Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.
     Cancer Res. 2008;68:8377-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. CASTRO-RIVERA E , Ran S, Brekken RA, Minna JD, et al
     Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.
     Cancer Res. 2008;68:8295-303.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. BARTOLOME RA , Wright N, Molina-Ortiz I, Sanchez-Luque FJ, et al
     Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.
     Cancer Res. 2008;68:8221-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. SINGH A , Boldin-Adamsky S, Thimmulappa RK, Rath SK, et al
     RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.
     Cancer Res. 2008;68:7975-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. LIU W , Cheng S, Asa SL, Ezzat S, et al
     The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.
     Cancer Res. 2008;68:8104-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. BURTON JB , Priceman SJ, Sung JL, Brakenhielm E, et al
     Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
     Cancer Res. 2008;68:7828-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
121. ZHENG M , Morgan-Lappe SE, Yang J, Bockbrader KM, et al
     Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
     Cancer Res. 2008;68:7570-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. CHEN HW , Lee JY, Huang JY, Wang CC, et al
     Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
     Cancer Res. 2008;68:7428-38.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. WINNER M , Meier J, Zierow S, Rendon BE, et al
     A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
     Cancer Res. 2008;68:7253-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. REAMON-BUETTNER SM , Borlak J
     Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors.
     Cancer Res. 2008;68:7587-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. ZOU W , Yue P, Khuri FR, Sun SY, et al
     Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation.
     Cancer Res. 2008;68:7484-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. SHIVAPURKAR N , Stastny V, Okumura N, Girard L, et al
     Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.
     Cancer Res. 2008;68:7448-56.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. WANG X , Yue P, Kim YA, Fu H, et al
     Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation.
     Cancer Res. 2008;68:7409-18.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. GUO W , Wu S, Liu J, Fang B, et al
     Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.
     Cancer Res. 2008;68:7403-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. MONNIER Y , Farmer P, Bieler G, Imaizumi N, et al
     CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.
     Cancer Res. 2008;68:7323-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. CRISWELL TL , Dumont N, Barnett JV, Arteaga CL, et al
     Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.
     Cancer Res. 2008;68:7304-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. ZHONG D , Liu X, Khuri FR, Sun SY, et al
     LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins.
     Cancer Res. 2008;68:7270-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. ZHONG L , Roybal J, Chaerkady R, Zhang W, et al
     Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.
     Cancer Res. 2008;68:7237-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. YAMAMOTO H , Shigematsu H, Nomura M, Lockwood WW, et al
     PIK3CA mutations and copy number gains in human lung cancers.
     Cancer Res. 2008;68:6913-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
134. HO-TIN-NOE B , Goerge T, Cifuni SM, Duerschmied D, et al
     Platelet granule secretion continuously prevents intratumor hemorrhage.
     Cancer Res. 2008;68:6851-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. RAINA K , Rajamanickam S, Singh RP, Deep G, et al
     Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
     Cancer Res. 2008;68:6822-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. CHIANG DY , Villanueva A, Hoshida Y, Peix J, et al
     Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
     Cancer Res. 2008;68:6779-88.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. VARELA JC , Imai M, Atkinson C, Ohta R, et al
     Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.
     Cancer Res. 2008;68:6734-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. MACIAS-PEREZ I , Borza C, Chen X, Yan X, et al
     Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.
     Cancer Res. 2008;68:6127-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. SEO HS , Liu DD, Bekele BN, Kim MK, et al
     Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer.
     Cancer Res. 2008;68:6065-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. MARTIN MD , Carter KJ, Jean-Philippe SR, Chang M, et al
     Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.
     Cancer Res. 2008;68:6251-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. LANDEMAINE T , Jackson A, Bellahcene A, Rucci N, et al
     A six-gene signature predicting breast cancer lung metastasis.
     Cancer Res. 2008;68:6092-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
142. SHIMAMURA T , Li D, Ji H, Haringsma HJ, et al
     Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.
     Cancer Res. 2008;68:5827-38.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. MARKS JL , Gong Y, Chitale D, Golas B, et al
     Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.
     Cancer Res. 2008;68:5524-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. WEI S , Shreiner AB, Takeshita N, Chen L, et al
     Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.
     Cancer Res. 2008;68:5432-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. LI W , Li F, Huang Q, Frederick B, et al
     Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo.
     Cancer Res. 2008;68:4990-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
146. CAREW JS , Nawrocki ST, Reddy VK, Bush D, et al
     The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib.
     Cancer Res. 2008;68:4783-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. PEINADO H , Moreno-Bueno G, Hardisson D, Perez-Gomez E, et al
     Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
     Cancer Res. 2008;68:4541-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. CRUZ-MUNOZ W , Man S, Xu P, Kerbel RS, et al
     Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
     Cancer Res. 2008;68:4500-5.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: